Targeting SLC7A11/xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti-tumor immune response.

Jin Y, Cai S, Zhou Y, Guo D, Zeng Y, Xu W, Sun Y, Shi Y, Xu Z, Liu Z, Luo P, Huang Z, Tang B

Open source

DOI
10.1002/imt2.248
Published
2024 Dec
Container
iMeta
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/imt2.248,
  title = {Targeting SLC7A11/xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti-tumor immune response.},
  author = {Jin Y and Cai S and Zhou Y and Guo D and Zeng Y and Xu W and Sun Y and Shi Y and Xu Z and Liu Z and Luo P and Huang Z and Tang B},
  year = {2024},
  journal = {iMeta},
  doi = {10.1002/imt2.248},
  url = {https://doi.org/10.1002/imt2.248}
}

RIS

TY  - JOUR
TI  - Targeting SLC7A11/xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti-tumor immune response.
AU  - Jin Y
AU  - Cai S
AU  - Zhou Y
AU  - Guo D
AU  - Zeng Y
AU  - Xu W
AU  - Sun Y
AU  - Shi Y
AU  - Xu Z
AU  - Liu Z
AU  - Luo P
AU  - Huang Z
AU  - Tang B
PY  - 2024
JO  - iMeta
DO  - 10.1002/imt2.248
UR  - https://doi.org/10.1002/imt2.248
ER  - 

APA

Y, J., S, C., Y, Z., D, G., Y, Z., W, X., Y, S., Y, S., Z, X., Z, L., P, L., Z, H., & B, T. (2024). Targeting SLC7A11/xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti-tumor immune response.. iMeta. https://doi.org/10.1002/imt2.248

Source records